Acute lymphoblastic leukemia: Clinical practice guidelines in oncology Journal Article
| Authors: | Alvarnas, J. C.; Brown, P. A.; Aoun, P.; Ballen, K. K.; Bellam, N.; Blum, W.; Boyer, M. W.; Carraway, H. E.; Coccia, P. F.; Coutre, S. E.; Cultrera, J.; Damon, L. E.; DeAngelo, D. J.; Douer, D.; Frangoul, H.; Frankfurt, O.; Goorha, S.; Millenson, M. M.; O'Brien, S.; Petersdorf, S. H.; Rao, A. V.; Terezakis, S.; Uy, G.; Wetzler, M.; Zelenetz, A. D.; Naganuma, M.; Gregory, K. M. |
| Article Title: | Acute lymphoblastic leukemia: Clinical practice guidelines in oncology |
| Abstract: | The inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) were developed as a result of meetings convened by a multidisciplinary panel of experts in 2011. These NCCN Guidelines provide recommendations on the diagnostic evaluation and workup for ALL, risk assessment, risk-stratified treatment approaches based on the Philadelphia chromosome status and age (adults vs. adolescents/young adults), assessment of minimal residual disease, and supportive care considerations. It is recommended that patients be treated at specialized centers with expertise in the management of ALL. © JNCCN - Journal of the National Comprehensive Cancer Network. |
| Keywords: | cancer chemotherapy; cancer survival; antibiotic therapy; gene mutation; overall survival; prednisone; review; doxorubicin; disease free survival; cytarabine; methotrexate; flow cytometry; nuclear magnetic resonance imaging; antineoplastic agent; imatinib; unindexed drug; reverse transcription polymerase chain reaction; computer assisted tomography; incidence; risk factors; cyclophosphamide; dexamethasone; steroid; vincristine; herpes simplex; pneumocystis pneumonia; practice guideline; dasatinib; acute lymphoblastic leukemia; risk assessment; protein tyrosine kinase inhibitor; fluorescence in situ hybridization; lumbar puncture; neoplasm, residual; daunorubicin; asparaginase; allogeneic hematopoietic stem cell transplantation; precursor cell lymphoblastic leukemia-lymphoma; immunophenotyping; antivirus agent; antiemetic agent; bcr abl protein; corticosteroid; nilotinib; recombinant granulocyte colony stimulating factor; cotrimoxazole; quinoline derived antiinfective agent; electrocardiogram; bone necrosis; fluconazole; foscarnet; ganciclovir; cytomegalovirus infection; clofarabine; mercaptopurine; valganciclovir; avascular necrosis; philadelphia chromosome; nelarabine; philadelphia chromosome positive cell; cancer prognosis |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 10 |
| Issue: | 7 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2012-07-01 |
| Start Page: | 858 |
| End Page: | 914 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 22773801 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 1 October 2012" - "Source: Scopus" |
Citation Impact
Related MSK Work